Across TCGA pan-cancer cohorts, BCAP31 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of BCAP31’s most consistent transcriptional readouts.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where BCAP31 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types BCAP31 is over-expressed in tumor.
HNSC, KIRC, and COAD are the cancer types where BCAP31 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BCAP31 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.